Ligand validation:5Z2U

TD6: (4S)-4-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-4-methyl-1,3lambda~5~-thiazol-2-yl}-4-hydroxybutanoic acid

TD6 is a Ligand Of Interest in 5Z2U designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5Z2U_TD6_H_601	83%	7%	0.115	0.974	2.91	2.03	6	7	5	0	100%	0.952
5Z2U_TD6_D_601	83%	7%	0.116	0.975	2.97	1.94	6	9	8	0	100%	0.937
5Z2U_TD6_E_601	75%	8%	0.133	0.968	3	1.69	6	10	4	0	100%	0.954
5Z2U_TD6_B_601	71%	3%	0.14	0.961	3.75	2.24	12	9	2	0	100%	0.933
5Z2U_TD6_G_601	67%	6%	0.152	0.962	3.05	2.01	7	10	1	0	100%	0.999
5Z2U_TD6_C_601	64%	7%	0.166	0.964	3.16	1.71	7	6	2	0	100%	0.995
5Z2U_TD6_A_601	60%	7%	0.154	0.941	3.21	1.68	6	10	13	0	100%	0.912
5EJ8_TD6_C_602	99%	15%	0.058	0.991	1.92	1.87	5	9	5	0	100%	1
5EJ7_TD6_F_601	97%	11%	0.065	0.98	2.5	1.67	5	7	9	0	100%	1
5EJ6_TD6_H_601	96%	7%	0.07	0.98	2.99	1.85	5	8	9	0	100%	1
5EJ4_TD6_B_602	95%	8%	0.075	0.98	2.79	1.8	5	10	5	0	100%	1
5Z2P_TD6_F_601	90%	3%	0.095	0.976	3.93	2.06	13	15	9	0	100%	0.957
5EJA_TD6_F_601	84%	7%	0.098	0.961	2.83	2.05	5	9	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.